16 results
Keyword Aremas Remove keyword
-
List item
Human medicine European public assessment report (EPAR): Prepandemic Influenza Vaccine (H5N1) (Split Virion, Inactivated, Adjuvanted) GlaxoSmithKline Biologicals
split influenza virus, inactivated, containing antigen: A/VietNam/1194/2004 (H5N1) like strain used (NIBRG-14), Influenza, Human; Immunization; Disease Outbreaks
Date of authorisation: 26/09/2008, Revision: 3, Withdrawn, Last updated: 21/03/2012 -
List item
Withdrawn application: Brilique
ticagrelor, date of withdrawal: 15/12/2021, Post-authorisation, Last updated: 01/04/2022 -
List item
Handling competing interests
Last updated: 04/01/2023 -
List item
Complaints
Last updated: 30/09/2011 -
List item
Management Board
Last updated: 31/12/2009 -
List item
Press release: European Medicines Agency's Management Board endorses revised EMA code of conduct
MB, Last updated: 17/06/2013 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 1-3 October 2012
PRAC, Last updated: 05/10/2012 -
List item
How we work
Last updated: 07/03/2016 -
List item
Press release: European Medicines Agency publishes revised Code of Conduct
Last updated: 18/03/2005 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 3-5 September 2012
European Medicines Agency, London, UK, from 03/09/2012 to 05/09/2012, Last updated: 02/06/2012 -
List item
Press release: Activities of former EMA Executive Director Thomas Lönngren
MB, Last updated: 21/03/2011 -
List item
EudraVigilance: electronic reporting
Last updated: 15/02/2022 -
List item
Public data from Article 57 database
Last updated: 17/10/2022 -
List item
Management Board meeting: 16 June 2016
European Medicines Agency, London, UK, 16/06/2016, Last updated: 21/06/2016 -
List item
PRAC: Committee agendas, minutes and meeting highlights report archive 2012-2013
Last updated: 01/01/2015 -
List item
PRAC: meeting archive 2012-2014
Last updated: 13/05/2016